GlassScriptPhysician profile
Darshan Doshi
NPI 1710120829
$730,469.56
in general payments reported to CMS, 2019-2025
24 companies · $43K in 2025
The $43K reported for 2025 was more than what 96% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,577 · 2020: $20K · 2021: $61K · 2022: $194K · 2023: $206K · 2024: $198K · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150K · Consulting Fee: $133K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $94K · Travel and Lodging: $46K · Food and Beverage: $21K · Honoraria: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $149,650.00 |
| Consulting Fee | $133,330.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $93,990.00 |
| Travel and Lodging | $46,115.12 |
| Food and Beverage | $20,992.68 |
| Honoraria | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $199,214.99 | 2019-2025 | Avvigo Guidance System, Opticross, Wolverine Coronary Cutting Balloon |
| Shockwave Medical, INC | $162,010.77 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $99,980.00 | 2020-2025 | Indigo System |
| Philips North America LLC | $72,491.70 | 2019-2025 | (9520) Igt Devices Undivided, (6554) Peripheral Vascular Undivided, Igt Devices Undivided |
| Abbott Laboratories | $64,544.30 | 2020-2025 | Dragonfly Opstar, Diamondback Coronary, Optis |
| Medtronic, INC. | $60,001.41 | 2021-2024 | Resolute Onyx, Onyx Frontier, Symplicity G3 |
| Acist Medical Systems, INC. | $27,488.07 | 2020-2024 | |
| Biotronik INC. | $14,878.50 | 2019-2025 | Orsiro Mission, Nhancer Rx |
| Chiesi USA, INC. | $6,152.04 | 2023-2025 | Kengreal |
| Cardinal Health 200 LLC | $5,353.52 | 2019-2021 | |
| Medtronic Vascular, INC. | $5,196.07 | 2019 | |
| Cardiovascular Systems INC. | $4,560.69 | 2021-2023 | Diamondback Coronary |
| Cordis US Corp. | $3,753.63 | 2021-2024 | Selution Slrpta |
| Asahi Intecc USA, INC. | $2,667.35 | 2023-2025 | Asahi Coronary Wires, Asahi Ptca Guide Wire |
| Spectrawave, INC | $728.54 | 2023-2025 | Hypervue Imaging System, Starlight Imaging Catheter, X1-Ffr |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $558.82 | 2019-2024 | Impella |
| Teleflex LLC | $193.16 | 2024 | Guideliner |
| Verge Medical, INC. | $185.49 | 2024 | |
| Edwards Lifesciences Corporation | $179.23 | 2020-2024 | |
| Cardiva Medical, INC. | $131.28 | 2019 | |
| Reflow Medical INC | $100.00 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.00 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$50,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darshan Doshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.